NCT03427437

Brief Summary

Caudal epidural block has been widely used, especially in pediatric surgery, to supply intraoperative and postoperative analgesia by affecting the region between T10 and S5 dermatomes in surgeries below the umbilical level. In conventional single-shot caudal block, the needle is inserted through the skin with a 60-80 degrees angle, until the sacrococcygeal ligament is passed through. Then the angle of the needle is decreased to 20-30 degrees and inserted further for an additional 2-3 mm, entering into the sacral canal.There is a risk of dural or vascular puncture when the needle is passing through sacral canal. Other complications are the soft tissue bulging, intraosseous injections and systemic toxicity. Many anatomical variations have been reported for sacral hiatus and sacral cornua. Therefore, the success rate of the classic caudal epidural anesthesia method in pediatric patients has been reported to be about 75%. With the usage of ultrasonography in regional anesthesia, many advantages have been reported. In particular ultrasonography under longitudinal image is helpful for visualization of the sacral hiatus, sacrococcygeal ligament, duramater, epidural space and the distribution of the local anesthetic agent Therefore, this significantly increases the block success and visualization of where local anesthetic is injected. The primary aim of this study was compare the success rate of ultrasound guided sacral hiatus injection and conventional sacral canal injection. Secondary objectives are; block performing time, number of needle puncture, success at first puncture and complication rate. However age and weight encountered wtih these complications are registered.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
275

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

January 23, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 9, 2018

Completed
Last Updated

February 9, 2018

Status Verified

February 1, 2018

Enrollment Period

9 months

First QC Date

January 23, 2018

Last Update Submit

February 8, 2018

Conditions

Keywords

sacral canalsacral hiatusultrasound

Outcome Measures

Primary Outcomes (1)

  • success rate of block

    absence of significant motor movements following surgical induction or aberrations in heart and or respiratory rates

    Intraoperative period

Secondary Outcomes (4)

  • block performing time

    Intraoperative first hour

  • first puncture success rate

    Intraoperative first hour

  • complications

    Intraoperative first hour

  • age and weight encountered complications

    Intraoperative first hour

Study Arms (2)

Conventional Group

ACTIVE COMPARATOR

Caudal block was performed by conventional method with %0,25 bupivacaine plus 1/200.000 adrenalin

Drug: BupivacaineDrug: Adrenalin

Ultrasound Group

ACTIVE COMPARATOR

Caudal block was performed by ultrasound method with %0,25 bupivacaine plus 1/200.000 adrenalin

Drug: BupivacaineDrug: AdrenalinDevice: Ultrasound

Interventions

caudal block was performed by conventional and ultrasound method with %0,25 bupivacaine + 1/200000 adrenalin

Also known as: Bustesin,Vem Drug, Ankara, Turkey
Conventional GroupUltrasound Group

caudal block was performed by conventional and ultrasound method with %0,25 bupivacaine + 1/200000 adrenalin

Also known as: Adrenalin 0.5 mg, Osel Drug, Istanbul, Turkey
Conventional GroupUltrasound Group

caudal block was performed by ultrasound method

Also known as: Sonosite M Turbo, USA
Ultrasound Group

Eligibility Criteria

Age6 Months - 8 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ASA (American Society of Anesthesiologist) I children aged between 6 months and 8 years old who underwent elective hypospadias, circumcision and both surgery

You may not qualify if:

  • Severe systemic disease, previous neurological or spinal disorder, coagulation anomaly, allergy against local anesthetics, local infection at block site or with a history of premature birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baskent University

Konya, Turkey (Türkiye)

Location

Related Publications (2)

  • Wang LZ, Hu XX, Zhang YF, Chang XY. A randomized comparison of caudal block by sacral hiatus injection under ultrasound guidance with traditional sacral canal injection in children. Paediatr Anaesth. 2013 May;23(5):395-400. doi: 10.1111/pan.12104. Epub 2012 Dec 29.

  • Ahiskalioglu A, Yayik AM, Ahiskalioglu EO, Ekinci M, Golboyu BE, Celik EC, Alici HA, Oral A, Demirdogen SO. Ultrasound-guided versus conventional injection for caudal block in children: A prospective randomized clinical study. J Clin Anesth. 2018 Feb;44:91-96. doi: 10.1016/j.jclinane.2017.11.011. Epub 2017 Nov 21.

MeSH Terms

Interventions

BupivacaineEpinephrineUltrasonography

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesEthanolaminesAmino AlcoholsAlcoholsBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Omer Karaca, MD

    Baskent University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Double Participant, Outcomes Assessor
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

January 23, 2018

First Posted

February 9, 2018

Study Start

February 1, 2017

Primary Completion

November 1, 2017

Study Completion

January 1, 2018

Last Updated

February 9, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations